China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)
2.190
-0.030 (-1.35%)
Sep 18, 2025, 4:08 PM HKT
HKG:0570 Revenue
China Traditional Chinese Medicine Holdings Co. had revenue of 7.46B CNY in the half year ending June 30, 2025, a decrease of -19.77%. This brings the company's revenue in the last twelve months to 15.59B, down -9.40% year-over-year. In the year 2024, China Traditional Chinese Medicine Holdings Co. had annual revenue of 16.51B, down -8.90%.
Revenue (ttm)
15.59B CNY
Revenue Growth
-9.40%
P/S Ratio
0.65
Revenue / Employee
930.44K CNY
Employees
16,753
Market Cap
11.18B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.51B | -1.61B | -8.90% |
Dec 31, 2023 | 18.12B | 3.82B | 26.69% |
Dec 31, 2022 | 14.30B | -4.75B | -24.92% |
Dec 31, 2021 | 19.05B | 4.25B | 28.68% |
Dec 31, 2020 | 14.81B | 485.22M | 3.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
JD Health International | 71.34B |
Hansoh Pharmaceutical Group Company | 14.45B |
Innovent Biologics | 12.52B |
WuXi Biologics | 21.98B |
Sino Biopharmaceutical | 33.49B |
CSPC Pharmaceutical Group | 28.49B |
Akeso | 2.75B |